Arbutus Biopharma (ABUS) Change in Receivables (2013 - 2026)
Arbutus Biopharma (ABUS) recorded Change in Receivables of $632,000 in Q2 2026, compared with -$157,000 a year earlier and down 99.6% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Change in Receivables (2013 - 2026) Analysis & Trends
On a TTM basis, Arbutus Biopharma's Change in Receivables came in at $179.38 million as of Jun 30, 2026; for FY2025, it came in at -$1.38 million.
- Across earlier years, Change in Receivables came in at $633,000 in FY2024 (+49.3%), $424,000 in FY2023 (-6.4%), $453,000 in FY2022 and -$413,000 in FY2021.
- Quarterly Change in Receivables has ranged from -$1.23 million in Q1 2025 to $178.74 million in Q1 2026 over the past five years.
- Per Business Quant, the preceding three quarters came in at $178.74 million (Q1 2026), $129,000 (Q4 2025) and -$120,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Arbutus Biopharma | 960.50 Mn | 587.48 Mn | - | 632,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 632,000.00 |
| Mar 31, 2026 | 178.74 Mn |
| Dec 31, 2025 | 129,000.00 |
| Sep 30, 2025 | -120,000.00 |
| Jun 30, 2025 | -157,000.00 |
| Mar 31, 2025 | -1.23 Mn |
| Dec 31, 2024 | 801,000.00 |
| Sep 30, 2024 | -159,000.00 |
| Jun 30, 2024 | -372,000.00 |
| Mar 31, 2024 | 363,000.00 |
| Dec 31, 2023 | -395,000.00 |
| Sep 30, 2023 | -443,000.00 |
| Jun 30, 2023 | -50,000.00 |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | -483,000.00 |
| Sep 30, 2022 | -135,000.00 |
| Jun 30, 2022 | 657,000.00 |
| Mar 31, 2022 | 414,000.00 |
| Dec 31, 2021 | -768,000.00 |
| Sep 30, 2021 | 369,000.00 |
API Access
Arbutus Biopharma Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();